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Background/aim: Anthrax is a zoonotic infection caused by Bacillus anthracis. We aimed to retrospectively evaluate cutaneous anthrax
cases that occurred during an outbreak in eastern Turkey (Hakkari-Yüksekova), where people mostly earn their living from animal
husbandry.
Materials and methods: Forty-six cutaneous anthrax patients that were admitted to the hospital during a very short duration of 3
months (June–August 2011) were evaluated.
Results: Out of 46 patients, 27 (52%) were women and 19 (48%) were men. The mean age was 37 ± 13 years. The distribution of
occupations was 1 butcher, 1 cook, 5 farmers, 27 housewives, 11 shepherds, and 1 teacher. Multiple lesions were seen in 7 patients
(15%) and the rest of the patients had only 1 lesion. We observed significant clinical differences among the cases and noted which
particular symptoms were associated with the various skin lesions. We treated our patients with intramuscular procaine penicillin or
oral ciprofloxacin/doxycycline.
Conclusion: Anthrax is an important health problem that can cause lethal outbreaks. Therefore, one should think about anthrax when
faced with a patient with history of animal contact that has a painless ulcer with edema and/or vesicles, especially in endemic countries
like Turkey.
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1. Introduction
Anthrax is a zoonotic infection caused by Bacillus anthracis,
which is a gram-positive, nonmotile, aerobic, sporeforming, encapsulated, large, rod-shaped bacterium (1). The
major virulence factors of Bacillus anthracis are encoded
on 2 virulence plasmids, pXO1 and pXO2. The tritoxinbearing plasmid pXO1 codes for three toxins, which cause
hemorrhage, edema, and necrosis. Bacillus anthracis has the
lethal factor, edema factor, and protective antigen, which
contains the host cell receptor component. The capsulebearing plasmid pXO2 encodes three genes (cap A, cap B, cap
C) involved in the synthesis of the polyglutamyl capsule that
inhibits host phagocytosis of the vegetative form of Bacillus
anthracis. Both plasmids are necessary for full virulence (2).
Anthrax can be found naturally in soil and commonly
affects domestic and wild animals around the world.
People can get sick with anthrax if they come in contact
with infected animals or contaminated animal products.
Anthrax could be used as a weapon of bioterrorism.
Human anthrax is classified in two ways:
* Correspondence: essrakural@gmail.com

(i) Based on the occupation of the individual:
a) Nonindustrial anthrax, which occurs in farmers,
butchers, veterinarians, etc.
b) Industrial anthrax, which appears in people who
process animal products like bones, hides, and
wool.
(ii) Based on how the disease was acquired:
a) Cutaneous anthrax is the most common clinical
form. The spores get into the skin, usually through
skin lacerations, abrasions, or biting flies when a
person handles infected animals or contaminated
animals products like wool, hides, or hair.
b) Pulmonary anthrax occurs via inhalation of the
spores.
c) Gastrointestinal anthrax occurs via ingestion of
spores.
Inside the infected host, the vegetative form of Bacillus
anthracis multiplies in the lymphatics and the spleen.
Simultaneously, a capsule and toxins are produced, which
eventually lead to the death of the animal. Then Bacillus
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2. Materials and methods
In this retrospective study, we aimed to evaluate cutaneous
anthrax cases during an outbreak in the eastern region of
Turkey, Hakkari-Yüksekova, where people mostly earn
their living from animal husbandry. The diagnosis of
patients was based upon a detailed history and physical
examination and direct microscopic examination of Gram
stain smears from the samples taken from the lesions. We
evaluated 46 patients that were admitted to the hospital
during a very short duration of 3 months (June–August
2011). Thirty-four patients were hospitalized and the
other 12 patients were treated as outpatients. Age, sex,
occupation, incubation period, what kind of animal
the patients had contact with, the location, number,
and type of lesion, the symptoms that accompanied the
lesion, and the choice of treatment were recorded. All the
characteristic lesions were photographed. Clinical samples
were obtained with needle aspiration from the vesicle in
the vesicular stage. During the eschar stage we lifted the
edge of the eschar with tweezers and obtained the fluid.
Gram stain was performed on the specimens and grampositive bacilli were observed. We took pictures from the
microscope, but imaging was unsuccessful. Culture tests
of the samples could not be performed because of a lack
of appropriate biosafety conditions of the laboratory in
the small, local hospital. Moreover, the laboratories able
to perform culture tests were far away and the transport of
these dangerous samples was hazardous.

We could not note the incubation period because the
patients could not precisely remember the day the lesions
began to occur; however, they all remembered when they
touched the contaminated animal products. Therefore, we
noted the time between contamination and coming for
examination was 4.67 ± 1.7 days. We recorded the parts
of the body where the lesions were localized. In our cases,
forearm, hand, or finger involvement was reported (Figure
2–4). Seven (15%) of the patients had multiple lesions and
39 (85%) of the patients had one lesion (Table).
We observed the clinical differences and noted what
kinds of signs accompanied the skin lesion. Pain in the arm,
fever, lymphadenopathy, and lymphangitis accompanied
the lesions (Table). The treatment chosen and its success
were also recorded. Only 4 of the patients had taken
antibiotic treatments before coming to the hospital.
After the spores of B. anthracis enter the skin through
an abrasion or cut, or the vegetative form is transferred
by insect bite, lesions usually appear and are followed by
papules and vesicles around the papules; edema develops
after the papule ulcerates and the characteristic eschar
occurs. When the patients came to the hospital we
observed papule, vesicle, and eschar forms of the disease.
Sixteen of the patients had vesicles, 7 of the patients had
papules, and 23 of the patients had eschars. Twenty-one
patients had edema accompanied by lesions (Table). Out
of the 46 patients, 14 patients were contaminated by cows
and 32 patients were contaminated by sheep.
Clinical findings and Gram staining were positive in
almost all (in 42 patients) of the cases. We were not able
to see the agent in only 4 patients. These 4 patients had
a history of contact with infected animals and typical
clinical findings. They had taken antibiotics before
coming for an examination and so we diagnosed anthrax
without microbial confirmation for these 4. We treated
our patients with intramuscular procaine penicillin or
oral ciprofloxacin/doxycycline (Figure 5). All our cases
were uncomplicated cutaneous anthrax. We treated
all of our patients for 7 days. We used intramuscular
procaine penicillin 2 × 1 800,000 units for 35 patients, oral
ciprofloxacin 500 mg 2 × 1 for 10 patients who wanted
outpatient treatment, and oral doxycycline 100 mg 2 × 1 for
1 patient who had a penicillin allergy. We had 1 pregnant
patient and we treated her with intramuscular penicillin.

3. Results
In our study, 46 patients were assessed in 3 months. Out
of 46 patients, 27 (59%) were female and 19 (41%) were
male. The youngest patient was 12 years old and the oldest
patient was 70 years old. The mean age was 37 ± 13.7 years
(Table). The distribution of occupations was 1 butcher,
1 cook, 5 farmers, 27 housewives, 11 shepherds, and 1
teacher (Figure 1).

4. Discussion
History and clinical appearance of the lesions are
important data for the diagnosis of cutaneous anthrax.
The diagnosis can be confirmed by detecting the agent in
staining (Giemsa, polychrome methylene blue, or grampositive), the growth of the organism in a culture, or both.
Nowadays serology, immunohistochemistry tests for
anthrax-specific protective antigens, and PCR are available

anthracis is released into the environment. Sporulation
requires the presence of free oxygen. Once outside the
host with exposure to air, the sporulation occurs and is
ready to be ingested by another animal. The ingestion by
the next host may happen at any time, from less than one
hour to many decades later. Humans can be infected with
these spores via microinjury (cutaneous), via ingestion of
infected meat or contaminated water (gastrointestinal), or
via inhalation of spores (pulmonary) (3).
Bacillus anthracis toxins cause local skin lesions resulting
in tissue necrosis. Organisms may also enter the lymphatic
system, resulting in lymphangitis and lymphadenopathy.
Occasionally skin lesions are accompanied by bacteremia
and systemic symptoms (4).
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Table. Age and sex distribution of patients; symptoms accompanying the lesions; number, type, and
location of lesions.
Number of patients (%)
Age

37 (12–70)

Sex
Male

19 (41%)

Female

27 (59%)

Symptoms accompanying the lesions
PIA*

14 (30%)

Fever

15 (33%)

LAP**

15 (33%)

LYM***

7 (15%)

PIA & fever & LAP & LYM

7 (15%)

PIA & fever & LAP

6 (13%)

Number of lesions
Multiple

7 (15%)

Single

39 (85%)

Location of lesions
Finger

32 (70%)

Hand & finger

3 (6%)

Hand

8 (18%)

Forearm

3 (6%)

Type of lesions
Papule

7 (15%)

Vesicular

16 (35%)

Eschar

23 (50%)

*PIA: pain in arm,**LAP: lymphadenopathy,*** LYM: lymphangitis.

Figure 1. Occupational distribution of patients.

Figure 2. A lesion on the forearm. Pain in arm, fever, and
lymphadenopathy accompanied the lesion.
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Figure 3. A lesion on the hand. Pain in arm, lymphadenopathy,
and fever accompanied the lesion.

Ciprofloxaci

74%
24%

Doxycyline
Penicillin

2%
Figure 5. Distribution of treatments.

in specialized laboratories for retrospective confirmation
of diagnosis (3,5). In our cases, Gram staining was
performed on the specimens and gram-positive bacilli
were observed. However, B. anthracis will die quickly after
appropriate antibiotic treatment. The characteristic lesion
can survive many weeks longer, because of the toxininduced damage. Clinicians need to be aware of the late
resolution and not extend the treatment unnecessarily (3).
The differential diagnosis of cutaneous anthrax includes
impetigo, cellulites, orf (ecthyma contagiosum), milker’s
nodules, cutaneous leishmaniasis, cutaneous tuberculosis,
arachnoid bites, plague, ulceroglandular tularemia, and
ecthyma gangrenosum (3,5,6). In our study, most of
the patients were female, but there was no significant
difference between sexes. In many studies it has also been
shown that there were no differences between the sexes
(7–10). The incubation period ranges from a few hours to
3 weeks, most often 2 to 6 days (2). We could not note the
incubation period because the patients could not precisely
remember the day the lesions began to occur; however,
they all remembered when they touched the contaminated
animal products. Therefore, we noted the time between
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Figure 4. Multiple lesions on the fingers. Pain in arm, fever, and
lymphadenopathy accompanied the lesions.

contamination and coming for examination, which was
4.67 ± 1.7 days. The duration was similar to the incubation
period. In our cases, forearm, hand, or finger involvement
was reported. Results were similar to the results of
studies that were reported before in Turkey (7,8,11–13).
Penicillin G is still the drug of choice, though doxycycline
or ciprofloxacin are now accepted as the best alternatives
in the treatment of naturally occurring cutaneous anthrax
(3,11,12,14,15). Penicillin alone is not recommended for
the life-threatening condition of anthrax (3,14). In severe
life-threatening cases, intravenous penicillin or another
chosen primary antibiotic, for example ciprofloxacin, may
be combined with other antibiotics. For anthrax meningitis,
the additional antibiotic is suggested to be vancomycin
or rifampicin; for gastrointestinal anthrax, streptomycin
or other aminoglycosides are suggested as well (3). Both
the Center for Disease Control (CDC) and the European
guidelines established that the first line of treatment should
be ciprofloxacin or doxycycline, with an additional one
or two antibiotics (either rifampicin, chloramphenicol,
clindamycin, clarithromycin, erythromycin, gentamicin,
streptomycin, or vancomycin) for inhalational anthrax. A
60-day treatment is recommended for just ciprofloxacin
according to the CDC and the European guidelines (16,17).
In studies in Turkey, penicillin resistance has not been
shown yet (11,14). Penicillin G is still the drug of choice,
though doxycycline or ciprofloxacin are now accepted as
the best alternatives in the treatment of naturally occurring
cutaneous anthrax (12,15). All of our cases were naturally
occurring anthrax. Therefore, we treated our patients with
intramuscular procaine penicillin or oral ciprofloxacin/
doxycycline. B. anthracis is generally sensitive to antibiotic
therapy but the clinical effects of the toxin may continue for
some time afterwards. Suggested durations are 3–7 days for
uncomplicated cutaneous anthrax and 10–14 days in cases
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of systemic anthrax (3). Penicillin (in combination with
rifampicin or vancomycin in life-threatening infections) is
suitable for pregnant women and nursing mothers, as well
as with children (3). We treated our pregnant patient with
intramuscular penicillin as well.
Studies have shown that contamination with cooked,
infected animal meat is not a risk factor for cutaneous
anthrax (18,19). Cooking (100–150 °C for 10 to 60
min) sterilizes raw animal materials, which may then be
consumed safely (20,21). Education of the community
to use personal protective equipment is important. They
should be encouraged to wear gumboots, gloves, and
aprons while slaughtering dead animals and handling
meat and skins. We also should emphasize the importance
of recognizing the disease and reporting it promptly. Early
reports of animal cases would allow secondary prevention
measures, including (a) decontamination of slaughtering
sites, (b) surveillance of animals, (c) advice to avoid
slaughtering ill and dead livestock, and (d) vaccination of
herbivores (22,23).
District health authorities and animal husbandry
personnel should be alerted promptly about the existence
of anthrax in their area to start control measures as early as
possible. In this way, mass vaccination of livestock, proper
disposal of carcasses with lime, and soil decontamination
in the affected areas and in nearby villages can be initiated
early (24).
The outbreak took place during a very short period
of time. A reason for the sudden outbreak is a lack of
enforcement of health and safety standards in this region. As
a result, there were a few animal clusters with sick animals
that were taken care of by uneducated animal husbandry

personnel and were owned by people unfamiliar with the
disease. Neither the owners nor the caretakers of the sick
animals reported the health of the animals to government
officials. This could be due to their ignorance or it could be
a deliberate choice so as not to incur financial losses. As a
consequence, preventative measures were not taken. The
general population that lives in this district is uneducated
about the disease as well and so they were contaminated
by those sick animals. Therefore, it is very important to
inform the general population and encourage animal
husbandry personnel to take precautions in order to
prevent an outbreak.
When we established the diagnosis of anthrax, we
informed the district health authorities and the district
governor; hence, we had the chance to contact the
owners of animal clusters and veterinarians, as well as
the population that lives in this district. Veterinarians
educated people to promptly report the death and illness
of animals. Informational flyers that include information
about the disease and protection methods were prepared
and information was given orally as well. Soil was
decontaminated with bleaching powder, the dead animals
were buried with lime, and healthy livestock was vaccinated.
We also encouraged people, especially housewives, to use
protective clothes like gloves while touching meat during
cooking. This is due to the fact that we had 28 people who
were infected by touching raw meat of ill animals during
cooking (27 housewives and 1 teacher) (Figure 3).
In conclusion, one should think about anthrax when
faced with a patient with a history of animal contact
who has painless ulcers with edema, vesicles, or papules,
especially in endemic countries like Turkey.
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